MeritValue

BIOMOLECULAR LIFE HOLDINGS, INC.

BIOMdata completeness 75%2 fiscal years on file

Data notes: no data for concept 'cash'; no data for concept 'totalDebt'; no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own
FigureFY 2013FY 2014
Revenue$01$01
Net income−$7.42M2−$6.19M2
Operating cash flow−$1.04M3−$1.91M3
Capital expenditure$04$04
Free cash flow (derived)−$1.04M3−$1.91M3
Total debt——
Cash & equivalents——
Diluted shares17.5M46.2M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.97
your share of equity
Profit it earned you last year
−$1.34
Free cash flow it threw off
−$0.41
Debt you’d be carrying
—

10 shares is a claim on −$0.97 of net worth that earned you −$1.34 and generated −$0.41 of cash last year.

iii. Is this a good business?
Moat signal · return on equity
— avg · 2y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+165% shares · 2y

Share count is up 165% over 2 years — owners have been diluted. Worth asking what they got for it.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0
DCF · Growth Exit 10Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
only 2 years of net income (need ≥3)
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2013-12-31 · accession 0001019687-15-001463 (Revenues)
  2. 10-K · period ending 2013-12-31 · accession 0001019687-15-001463 (NetIncomeLoss)
  3. 10-K · period ending 2013-12-31 · accession 0001019687-15-001463 (NetCashProvidedByUsedInOperatingActivitiesContinuingOperations)
  4. 10-K · period ending 2013-12-31 · accession 0001019687-15-001463 (PaymentsToAcquirePropertyPlantAndEquipment)